1074
R. Saladino et al. / Tetrahedron 61 (2005) 1069–1075
monoterpene derivatives 11–13 were obtained from a
commercial source (Aldrich).
after the MnO2 addition), the suspension was filtered and the
filtrate dried over Na2SO4. After the evaporation of the
solvent, the crude product was analysed by gas chromato-
graphy–mass spectroscopy and when necessary purified by
flash-chromatography.
4.2. Synthesis of Lewis base adduct of MTO, compounds
I–III.
Lewis base adducts of MTO I–III containing the mono-
dentate ligand 4-methoxyaniline and the bidentate aromatic
and aliphatic ligands 2-methyl aminopyridine and trans-1,2-
diaminocyclohexane, respectively, were prepared as model
compounds following a synthetic procedure previously
reported in the literature.27 As a general procedure 1.0 mmol
of the appropriate monodentate ligand or 0.5 mmol of
bidentate ligands were added to 1.0 mmol of MTO in
toluene (10 mL) at room temperature. A yellow precipitate
was immediately formed. The reaction mixture was
concentrated, cooled to K35 8C and the precipitate isolated
by filtration.
4.4.2. Epoxidation with MTO and microencapsulated
Lewis base adducts of MTO mI–mIII. To the suspension
of the appropriate catalyst mI–mIII (1.0% in weight of
MTO adduct, loading factor 1.0) in 5.0 mL of CH3CN/
CH2Cl2 (ratio 1/1 v/v) at 25 8C or K10 8C (see Tables 1 and
3) was added the substrate (1.0 mmol) to be oxidised and
H2O2 (1.5 mmol, 35% aq solution). At the end of the
reaction the catalyst was recovered by filtration and washed
with CH2Cl2. MnO2 (2.0 mg) was added to degrade the
excess of primary oxidant, the suspension was again filtered
and the filtrate dried over Na2SO4. After the evaporation of
the solvent, the crude product was analysed by gas
chromatography–mass spectroscopy and when necessary
purified by flash-chromatography. Identity of products was
confirmed by 200 MHz 1H and 13C NMR and mass-
spectroscopy (EI) analyses. Spectra were compared with
those of authentic compounds. Listed data are available for
cycloalkene oxides and styrene oxide,19b a-pinene oxide,28
3-carene oxide29 and 1,2-limonene oxide.30
4.2.1. [4-(Methoxyaniline)]methyltrioxorhenium (VII)
1
(I). IR [KBr]: n (ReZO) cmK1: 909, 934, 962. H NMR
(CDCl3) d ppm: 2.56 (s, 3H), 3.39 (br. s, 2H), 3.73 (s, 3H),
6.63 (d, JZ9.16 Hz, 2H), 6.73, 6.63 (d, JZ8.13 Hz, 2H).
C8H12NO4Re calcd: C 25.80, H 3.25, N 3.76; Found C
25.93, H 3.15, N 3.74.
4.4.3. a-3,4-Epoxycarene 14. Oil, bp 182–184 8C [lit.31, bp
182 8C], dH [CDCl3, 200 MHz] 0.45 (1H, ddd, JZ2.2, 8.9,
9.1 Hz, H-1 eq), 0.53 (1H, ddd, JZ2.3, 8.9, 9.1 Hz, H-6 eq),
0.73 (3H, s, H-8), 1.01 (3H, s, H-9), 1.26 (3H, s, H-10), 1.49
(1H, dd, JZ2.2, 16.2 Hz, H-2 eq), 1.64 (1H, dt, JZ2.3,
16.4 Hz, H-5 eq), 2.15 (1H, dd, JZ9.1, 16.2 Hz, H-2 ax),
2.30 (1H, ddd, JZ1.9, 8.9, 16.4 Hz, H-5 ax), 2.85 (1H, t,
JZ1.9 Hz, H-4). dC [CDCl3, 200 MHz] 13.8 (C-1), 14.6
(C-8), 15.9 (C-6), 16.0 (C-7), 19.1 (C-5), 23.1 (C-10), 23.3
(C-2), 26.7 (C-9), 56.1 (C-3), 58.3 (C-4). MS (EI) m/z 152
(MC, 2), 137 (42), 109 (62), 91 (24), 81 (45), 67 (82), 43
(100), 39 (56).
4.2.2. [2-(Aminomethyl)pyridine]methyltrioxorhenium
(II). IR [KBr]: n (ReZO) cmK1: 908, 935. 1H NMR
(CD3CN) d ppm: 2.12 (s, 3H), 3.53 (br. s, 2H), 5.04 (d, JZ
22.0 Hz, 1H), 6.09 (d, JZ22.0 Hz, 1H), 8.19 (m, 1H), 8.30
(m, 1H), 8.83 (m, 1H), 9.23 (m, 1H). C7H11N2O3Re calcd: C
25.53, H 3.10, N 7.84; Found C 25.41, H 3.08, N 7.78.
4.3. Synthesis of microencapsulated Lewis base adduct of
MTO, compounds I–III
Microencapsualted Lewis base adduct of MTO, compounds
mI–mIII, were prepared following a modified procedure
previously reported for the synthesis of polystyrene/MTO
catalyst.19b In summary, to a suspension of 600 mg of
polystirene in 4 mL of tetrahydrofuran (THF) was added
0.3 mmol of the appropriate adduct I–III, and the mixture
was stirred for 1 h using a magnetic stirrer. Coocervates
were found to envelop the solid core dispersed in the
medium and 5.0 mL of hexane were added to harden the
capsule walls. The solvent was removed by filtration, and
the solid residue was washed with ethyl acetate and finally
dried under high vacuum. In each case, MTO had
completely become bound to the polymer. This result was
confirmed by spectroscopic analysis of the residue obtained
after evaporation of the organic layers. The catalysts were
used without any further purification.
4.4.4. a-Pinene oxide 16. Oil, bp 102–104 8C /50 mm
[lit.32, bp 102–103 8C/50 mmHg], dH [CDCl3, 200 MHz]
0.91 (3H, s, CH3), 1.30 (3H, s, CH3), 1.32 (3H, s, CH3), 1.59
(1H, m, CH), 1.72 (1H, m, CH), 1.90–2.05 (4H, m, CH2),
3.08 (1H, m, CH). dC [CDCl3, 200 MHz] 60.23 (s, C-1),
56.7 (d, C-2), 44.9 (d, C-6), 40.4 (s, C-10), 39.6 (d, C-4),
27.64 (t, C-5), 26.72 (q, C-9), 25.87 (t, C-3), 22.41 (q, C-8),
20.18 (q, C-7). MS (EI) m/z 152 (MC).
4.4.5. Limonene oxide 19. Oil, bp 113–114 8C /50 mm
[lit.33, bp 113–114 8C/50 mmHg], dH [CDCl3, 200 MHz]
4.65 (2H, m, CH2), 3.10 (1H, m, CH), 2.97 (1H, m, CH),
2.20–1.40 (6H, 3xm, CH2), 1.55 (3H, s, CH3), 1.20 (3H, s,
CH3). dC [CDCl3, 200 MHz] 20.19 (q, C-7), 22.05 (q, C-8),
25.81 (t, C-3), 28.53 (t, C-5), 30.66 (t, C-6), 40.68 (d, C-4),
57.35 (s, C-1), 59.24 (d, C-2), 109.0 (d, C-8), 148.78 (s,
C-7). MS (EI) m/z 152 (MC).
4.4. Epoxidation. General procedure
4.4.1. Epoxidation with MTO and Lewis base adducts of
MTO I–III. To the suspension of the appropriate catalyst (1
or I–III, 1.0% in weight) in 5.0 mL of CH3CN/CH2Cl2
(ratio 1/1 v/v) at 25 8C or K10 8C (see Tables 1 and 3) was
added the substrate (1.0 mmol) to be oxidised and H2O2
(1.5 mmol, 35% water solution). At the end of the reaction
MnO2 (2.0 mg) was added to degrade the excess of primary
oxidant (the reaction mixture was found to be unchanged
Acknowledgements
MIUR (PRIN COFIN 2003) is acknowledged for financial
support.